Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 871-878

  Yunokawa, Mayu ^a,b   Tanimoto, Keiji ^a   Nakamura, Hideaki ^a   Nagai, Nobutaka ^b   Kudo, Yoshiki ^b   Kawamoto, Takeshi ^b   Kato, Yukio ^b   Hiyama, Eiso ^a   Hiyama, Keiko ^a   Nishiyama, Masahiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Differentiated embryo chondrocytes; Endometrial carcinoma; Gene expression; Hypoxia

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BHLHB3 PROTEIN, HUMAN; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; DEC1 PROTEIN, HUMAN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SLC2A1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANOXIA; ARTICLE; CARCINOMA; CELL CULTURE; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR GENE;

ANOXIA; ANTIGENS, NEOPLASM; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBONIC ANHYDRASES; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34249932550     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.871     Document Type: Article

References (28)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote I: Endometrial cancer. Lancet 366: 491-505, 2005. (Pubitemid 41111699)
2. Prat J: Prognostic parameter of endometrial carcinoma. Hum Pathol 35: 649-662, 2004.
3. Shiozawa T and Konishi I: Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment. Int J Clin Oncol 11: 13-21, 2006. (Pubitemid 43320322)
4. Vaupel P, Kallinowski F and Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors (Review). Cancer Res 49: 6449-6465, 1989. (Pubitemid 20008770)
5. Semenza GL: Targeting HIF-1 for cancer therapy. Nature Rev 3: 721-732, 2003.
6. Kondoh-Kizaka S, Inoue M, Harada H and Hiraoka M: Tumor hypoxia: A target for selective cancer therapy. Cancer Sci 94: 1021-1028, 2003. (Pubitemid 38035514)
7. Poellinger L and Johnson RS: HIF-1 and hypoxic response: the plot thickens. Curr Opin Genet Dev 14: 81-85, 2004. (Pubitemid 38167481)
8. Fandrey J, Gorr TA and Gassmann M: Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res (in press).
9. Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H and Kato Y: Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 277: 47014-47021, 2002. (Pubitemid 36159208)
10. Shen M, Kawamoto T, Teramoto M, Makihira S, Fujimoto K, Yan W, Noshiro M and Kato Y: Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway. Eur J Cell Biol 80: 329-334, 2001. (Pubitemid 32514827)
11. Fujimoto K, Shen M, Noshiro M, Matsubara K, Shingu S, Honda K, Yoshida E, Suardita K, Matsuda Y and Kato Y: Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins. Biochem Biophys Res Commun 280: 164-171, 2001. (Pubitemid 32917491)
12. Shen M, Yoshida E, Yan W, Kawamoto T, Suardita K, Koyano Y, Fujimoto K, Noshiro M and Kato Y: Basic Helix-loop-Helix protein DEC1 promotes Chondrocyte differenciation at the early and terminal stages. J Biochem Chem 51: 50112-50120, 2002. (Pubitemid 36014464)
13. Yun Z, Maecker HL, Johonson RS and Giaccia AJ: Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 3: 331-341, 2002. (Pubitemid 34266118)
14. Hamaguchi H, Fujimoto K, Kawamoto T, Noshiro M, Maemura K, Takeda N, Nagai R, Furukawa M, Honma S, Honma K, Kurihara H and Kato Y: Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. Biochem J 382: 43-50, 2004. (Pubitemid 39141564)
15. Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y and Honma K: Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419: 841-844, 2002. (Pubitemid 35238570)
16. Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC and Fox SB: The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 91: 954-958, 2004. (Pubitemid 39273790)
17. Currie MJ, Hanrahan V, Gunningham SP, Morrin HR, Frampton C, Han C, Robinson BA and Fox SB: Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1α) and HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol 57: 829-834, 2004. (Pubitemid 39061431)
18. Turley H, Wykoff CC, Troup S, Watson PH, Gatter KC and Harris AL: The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumors. J Pathol 203: 808-813, 2004. (Pubitemid 38961567)
19. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC and Harris AL: DEC1 (STRA13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol 200: 222-228, 2003. (Pubitemid 36748031)
20. Robertson N, Potter C and Harris AL: Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion: Cancer Res 64: 61610-6165, 2004.
21. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H and Verma A: Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162: 1789-1806, 2003. (Pubitemid 36613038)
22. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM and Stratford IJ: GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104: 85-91, 2003. (Pubitemid 36184150)
23. Wang BY, Kalir T, Sabo E, Sherman DE, Cohen C and Burstein DE: Immunohistchemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88: 2772-2781, 2000.
24. Nisahida M: The Ishikawa cells from birth to the present. Hum Cell 15: 104-117, 2002.
25. Kallio PJ, Pongratz I, Gradin K, McGuire J and Poellinger L: Activation of hypoxia-inducible factor-1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA 94: 5667-5672, 1997. (Pubitemid 27241827)
26. Tanimoto K, Makino Y, Pereira T and Poellinger L: Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J 19: 4298-4309, 2000. (Pubitemid 30623741)
27. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A: Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 14: 34-44, 2000. (Pubitemid 30051577)
28. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D and Giaccia AJ: Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14: 391-396, 2000. (Pubitemid 30131884)